169 related articles for article (PubMed ID: 11008132)
21. Surface decorated nanoparticles as surrogate carriers for improved transport and absorption of epirubicin across the gastrointestinal tract: Pharmacokinetic and pharmacodynamic investigations.
Tariq M; Alam MA; Singh AT; Panda AK; Talegaonkar S
Int J Pharm; 2016 Mar; 501(1-2):18-31. PubMed ID: 26812610
[TBL] [Abstract][Full Text] [Related]
22. Epirubicin loaded with propylene glycol liposomes significantly overcomes multidrug resistance in breast cancer.
Zhao YZ; Dai DD; Lu CT; Chen LJ; Lin M; Shen XT; Li XK; Zhang M; Jiang X; Jin RR; Li X; Lv HF; Cai L; Huang PT
Cancer Lett; 2013 Mar; 330(1):74-83. PubMed ID: 23186833
[TBL] [Abstract][Full Text] [Related]
23. Influence of monocaprin on the permeability of a diacidic drug BTA-243 across Caco-2 cell monolayers and everted gut sacs.
Brown JR; Collett JH; Attwood D; Ley RW; Sims EE
Int J Pharm; 2002 Oct; 245(1-2):133-42. PubMed ID: 12270250
[TBL] [Abstract][Full Text] [Related]
24. The Use of a Liposomal Formulation Incorporating an Antimicrobial Peptide from Tilapia as a New Adjuvant to Epirubicin in Human Squamous Cell Carcinoma and Pluripotent Testicular Embryonic Carcinoma Cells.
Lo YL; Lee HP; Tu WC
Int J Mol Sci; 2015 Sep; 16(9):22711-34. PubMed ID: 26393585
[TBL] [Abstract][Full Text] [Related]
25. Absorption Characteristics of Chitobiose and Chitopentaose in the Human Intestinal Cell Line Caco-2 and Everted Gut Sacs.
Chen P; Zhao M; Chen Q; Fan L; Gao F; Zhao L
J Agric Food Chem; 2019 Apr; 67(16):4513-4523. PubMed ID: 30929431
[TBL] [Abstract][Full Text] [Related]
26. In vitro study on the transport of zinc across intestinal epithelial cells using Caco-2 monolayers and isolated rat intestinal membranes.
Yasuno T; Okamoto H; Nagai M; Kimura S; Yamamoto T; Nagano K; Furubayashi T; Yoshikawa Y; Yasui H; Katsumi H; Sakane T; Yamamoto A
Biol Pharm Bull; 2012; 35(4):588-93. PubMed ID: 22466565
[TBL] [Abstract][Full Text] [Related]
27. Evidence of efflux-mediated and saturable absorption of rifampicin in rat intestine using the ligated loop and everted gut sac techniques.
Mariappan TT; Singh S
Mol Pharm; 2004; 1(5):363-7. PubMed ID: 16026006
[TBL] [Abstract][Full Text] [Related]
28. Effect of pluronic P123 and F127 block copolymer on P-glycoprotein transport and CYP3A metabolism.
Guan Y; Huang J; Zuo L; Xu J; Si L; Qiu J; Li G
Arch Pharm Res; 2011 Oct; 34(10):1719-28. PubMed ID: 22076772
[TBL] [Abstract][Full Text] [Related]
29. MRP2 mediated drug-drug interaction: indomethacin increases sulfasalazine absorption in the small intestine, potentially decreasing its colonic targeting.
Dahan A; Amidon GL
Int J Pharm; 2010 Feb; 386(1-2):216-20. PubMed ID: 19944137
[TBL] [Abstract][Full Text] [Related]
30. Hydrolysis and Transport of Egg White-Derived Peptides in Caco-2 Cell Monolayers and Everted Rat Sacs.
Wang L; Ding L; Du Z; Yu Z; Liu J
J Agric Food Chem; 2019 May; 67(17):4839-4848. PubMed ID: 30969123
[TBL] [Abstract][Full Text] [Related]
31. Improved delivery of cromolyn from oral proliposomal beads.
Deshmukh DD; Ravis WR; Betageri GV
Int J Pharm; 2008 Jun; 358(1-2):128-36. PubMed ID: 18400424
[TBL] [Abstract][Full Text] [Related]
32. Formononetin potentiates epirubicin-induced apoptosis via ROS production in HeLa cells in vitro.
Lo YL; Wang W
Chem Biol Interact; 2013 Oct; 205(3):188-97. PubMed ID: 23867903
[TBL] [Abstract][Full Text] [Related]
33. [The inhibitory effect of pluronic on P-glycoprotein drug pump].
Huang JG; Si LQ; Zuo KY; Wu XG; Qiu J; Li G
Yao Xue Xue Bao; 2007 Sep; 42(9):989-94. PubMed ID: 18050744
[TBL] [Abstract][Full Text] [Related]
34. Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
Lin GL; Ting HJ; Tseng TC; Juang V; Lo YL
PLoS One; 2017; 12(10):e0185625. PubMed ID: 28968471
[TBL] [Abstract][Full Text] [Related]
35. Small intestinal efflux mediated by MRP2 and BCRP shifts sulfasalazine intestinal permeability from high to low, enabling its colonic targeting.
Dahan A; Amidon GL
Am J Physiol Gastrointest Liver Physiol; 2009 Aug; 297(2):G371-7. PubMed ID: 19541926
[TBL] [Abstract][Full Text] [Related]
36. Bioactive self-assembling lipid-like peptides as permeation enhancers for oral drug delivery.
Karavasili C; Spanakis M; Papagiannopoulou D; Vizirianakis IS; Fatouros DG; Koutsopoulos S
J Pharm Sci; 2015 Jul; 104(7):2304-11. PubMed ID: 25994901
[TBL] [Abstract][Full Text] [Related]
37. Comparison of different intestinal epithelia as models for absorption enhancement studies.
Legen I; Salobir M; Kerc J
Int J Pharm; 2005 Mar; 291(1-2):183-8. PubMed ID: 15707745
[TBL] [Abstract][Full Text] [Related]
38. An Investigation into the Role of P-Glycoprotein in the Intestinal Absorption of Repaglinide: Assessed by Everted Gut Sac and Caco-2 Cell Line.
Yaghoobian M; Haeri A; Bolourchian N; Shahhosseini S; Dadashzadeh S
Iran J Pharm Res; 2019; 18(1):102-110. PubMed ID: 31089348
[TBL] [Abstract][Full Text] [Related]
39. Enhancing effect of N-octyl-O-sulfate chitosan on etoposide absorption.
Mo R; Xiao Y; Sun M; Zhang C; Ping Q
Int J Pharm; 2011 May; 409(1-2):38-45. PubMed ID: 21356302
[TBL] [Abstract][Full Text] [Related]
40. Raltegravir permeability across blood-tissue barriers and the potential role of drug efflux transporters.
Hoque MT; Kis O; De Rosa MF; Bendayan R
Antimicrob Agents Chemother; 2015 May; 59(5):2572-82. PubMed ID: 25691630
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
